Good morning and welcome to today's report.

The agenda is complete.

Mello 2025: just a quick reminder that this fantastic investor conference is getting underway in London today. Ed, Graham & Mark will be there as will many of the companies we report on in these pages. I believe a few tickets may still be available - we are able to offer a discount code "STOCKOPEDIA50", which can be used at this link.

Warren Buffett's evolving style: finding our own style as investors can be a key element of success. Alex has published an interesting new article today charting the evolution of Warren Buffett's style over his career as an investor - it's well worth a read.

14:20: we're wrapping up the report for today - see you tomorrow!


Companies Reporting

Name (Mkt Cap)RNSSummaryOur view (Author)

British American Tobacco (LON:BATS) (£73.5bn)

H1 trading update

On track for FY25, revenue slightly ahead of guidance, exp FY rev +1-2%, adj op profit +1.5-2.5%.
Market share -0.1% in top markets, but +0.1% in core US market.
US on track for return to revenue and profit growth in H1 and FY.

AMBER/GREEN (Roland) [no section below]
This business has faced some headwinds over the last year or so, but still appears to be on track to deliver operationally. While leverage is slightly higher than I’d like, I can’t ignore the prodigious cash generation and tempting 7.4% dividend yield.
BAT’s £10bn shareholding in ITC (NSI:ITC) and its significant next-generation business are additional attractions that could help to support the longer-term evolution of the group, in my view. I’m comfortable maintaining Graham’s previous moderately positive view today.

Rotork (LON:ROR) (£2.6bn)

Share buyback programme

Commenced buyback programme up to £50m.

Pennon (LON:PNN) (£2.4bn)

Full Year Results

Rev +15%, adj EBITDA flat at £335.6m. Adj LBT of £35.1m. Outlook: return to profitability.

Chemring (LON:CHG) (£1.3bn)

Interim Results

Rev +5%, adj PBT +6% to £24.1m. Record order book of £1.3bn, outlook in line w/ exps.AMBER (Roland)
Today’s results from this defence contractor look solid enough and show very strong growth in the order backlog. However, much of this seems to be being driven by Energetics, with weakness elsewhere in the business. This situation may improve in H2, but I can’t help feeling that a fair amount of growth is…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here